The possibility of inhibiting BET proteins has been firstly explored, with good results, in NUT midline carcinoma (NMC), a rare subtype of squamous carcinoma characterized by the fusion oncoprotein BRD4‐NUT [1, 2]. Here, BRD4 is linked to nut midline carcinoma.